The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this? Vermersch P, Berger T, Gold R, Lukas C, Rovira A, Meesen B, Chard D, Comabella M, Palace J, Trojano M Mult Scler. 2016 Aug; 22(2 Suppl):18-33. PMID: 27465613. Abstract CommentRecommendBookmarkWatch